drugset / Trial / NCT02101229
Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
Phase 2/3
Completed
17 enrolled
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
RandomizedCrossoverOpen-labelHealth-services research
Summary
To assess whether the DIABELOOP algorithm provides better glycemic control than the usual algorithm of T1D patients on pump therapy: * at meals, with CHO roughly assessed by the patient. * during and after physical activity sessions qualified as moderate by the patient. Primary endpoint : time within the glycemic reference range. The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Grenoble, and CHU of Montpellier.
Timeline
- Start
- 2014-05
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | — | — |